| 多替拉韦钠片 | ViiV Healthcare B.V. | 10mg (按C₂₀H₁₉F₂N₃O₅计) | Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) | 国药准字HJ20191012 | 2021-01-28 | 查看 |
| 多替拉韦钠片 | ViiV Healthcare B.V. | 25mg (按C₂₀H₁₉F₂N₃O₅计) | Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) | 国药准字HJ20191013 | 2021-01-28 | 查看 |
| 卡替拉韦注射液 | ViiV Healthcare BV | 2ml∶0.4g | Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) | 国药准字HJ20230092 | 2023-07-11 | 查看 |
| 卡替拉韦钠片 | ViiV Healthcare BV | 30mg(按C₁₉H₁₇F₂N₃O₅计) | Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) | 国药准字HJ20230094 | 2023-07-11 | 查看 |
| 卡替拉韦注射液 | ViiV Healthcare BV | 3ml∶0.6g | Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) | 国药准字HJ20230093 | 2023-07-11 | 查看 |
| 多替拉韦钠分散片 | ViiV Healthcare BV | 5mg(以多替拉韦计) | Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) | 国药准字HJ20230060 | 2023-05-29 | 查看 |
| 糠酸氟替卡松鼻用喷雾剂 | GlaxoSmithKline (Ireland) Limited | 每喷含糠酸氟替卡松27.5μg | Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) | 国药准字HJ20170105 | 2021-11-02 | 查看 |
| 糠酸氟替卡松鼻用喷雾剂 | GlaxoSmithKline (Ireland) Limited | 每喷含糠酸氟替卡松27.5μg | Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) | 国药准字HJ20170104 | 2021-11-02 | 查看 |
| 氟替美维吸入粉雾剂 | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND | 每泡含糠酸氟替卡松100µg、乌美溴铵62.5µg(按C₂₉H₃₄NO₂计)与三苯乙酸维兰特罗25µg(按C₂₄H₃₃Cl₂NO₅计)，递送剂量为糠酸氟替卡松92µg、乌美溴铵55µg(按C₂₉H₃₄NO₂计)与三苯乙酸维兰特罗22µg(按C₂₄H₃₃Cl₂NO₅计)。 | Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) | 国药准字HJ20190055 | 2024-07-23 | 查看 |
| 多替阿巴拉米片 | ViiV Healthcare BV | 每片含多替拉韦钠(以多替拉韦计)50mg、硫酸阿巴卡韦(以阿巴卡韦计)600mg和拉米夫定300mg | Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) | 国药准字HJ20170345 | 2022-05-23 | 查看 |
